Total Neoadjuvant Treatment Combined With Adaptive Radiotherapy for Rectal Cancer

Abroad (travel likely)Recruiting

Conditions

Rectal Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Haukeland University Hospital, Bergen, Norway

Study leads

Unn Hege Lilleøren, MD
Principal Investigator
Dept. of Oncology and Medical Physics, Haukeland University Hospital, Bergen, Norway

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Diffuse Astrocytoma, IDH-Mutant · Glioblastoma, IDH-wildtype · Brain Metastases, Adult

Abroad (travel likely)RecruitingPHASE1, PHASE2

Beverly Hills, United States · Glendale, United States

Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"

Malignant Head and Neck Neoplasm · Malignant Neoplasm · Metastatic Malignant Neoplasm in the Neck

Abroad (travel likely)Recruiting

Houston, United States

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, The ERASur Study

Metastatic Colorectal Adenocarcinoma · Stage IV Colorectal Cancer AJCC v8

Abroad (travel likely)RecruitingPHASE3

Kingman, United States · Phoenix, United States

Total Neoadjuvant Therapy With mFOLFOX and Short-course Radiation in Resectable Rectal Cancer

Rectal Cancer

Abroad (travel likely)RecruitingPHASE2

Richmond, United States · Richmond, United States